Answers are grounded in this paper and cite their sources.
Methylation of the MGMT promoter in gliomas is a useful predictor of the responsiveness of the tumors to alkylating agents.
No takes yet. Share an insight, caveat, or question.
Esteller et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: